Estudios Observacionales
Portada » Estudios Observacionales
- S-REAL
- LORLAPULM
- PLANET
- LUDICAS
S-REAL
S-REAL
(GECP 19/02)
First Real-world Data on Unresectable Stage III NSCLC Patients Treated With Durvalumab After Chemoradiotherapy.
LORLAPULM
LORLAPULM
(GECP 21/04)
Retrospective, Observational Study On The Efficacy And Safety Of Lorlatinib In ALK or ROS1 Metastatic Non-Small Cell Lung Cancer Patients Treated Within The Compassionate Use Program In Spain.
PLANET
PLANET
(GECP 21/03)
Retrospective, Observational Study On The Efficacy And Safety Of Lorlatinib In ALK or ROS1 Metastatic Non-Small Cell Lung Cancer Patients Treated Within The Compassionate Use Program In Spain.
LUDICAS
